5-(3-{[(2,1,3-benzoxadiazol-4-ylsulfonyl)amino]methyl}phenyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide | 919346-11-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 5-(3-{[(2,1,3-benzoxadiazol-4-ylsulfonyl)amino]methyl}phenyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide
• 英文别名: 5-[3-[(2,1,3-benzoxadiazol-4-ylsulfonylamino)methyl]phenyl]-3-(1-ethylsulfonylpiperidin-4-yl)-1H-indole-7-carboxamide
• CAS: 919346-11-5
• 化学式: C₂₉H₃₀N₆O₆S₂
• 分子量: 622.726
• InChiKey: RUISFYQGSWWSPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  43
• 可旋转键数：
  9
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  198
• 氢给体数：
  3
• 氢受体数：
  10

文献信息

• CHEMICAL COMPOUNDS
  申请人：Deng Jianghe

  公开号：US20090143372A1

  公开（公告）日：2009-06-04

  The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I: where R1, R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  这项发明涉及新型吲哚羧酰胺衍生物。具体而言，该发明涉及符合以下式I的化合物： 其中R1、R2、R3、U和V如下定义，并且其药学上可接受的盐。该发明的化合物是IKK2的抑制剂，可用于治疗与不当IKK2（也称为IKKβ）活性相关的疾病，如类风湿性关节炎、哮喘和慢性阻塞性肺病（COPD）。因此，该发明进一步涉及包含该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包含该发明化合物的药物组合物抑制IKK2活性和治疗相关疾病的方法。
• US8063071B2
  申请人：——

  公开号：US8063071B2

  公开（公告）日：2011-11-22
• US8354406B2
  申请人：——

  公开号：US8354406B2

  公开（公告）日：2013-01-15
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2007005534A2

  公开（公告）日：2007-01-11

  (EN) The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I: Formula (I) where R1 , R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKK&bgr;) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.(FR) L'invention concerne de nouveaux dérivés d'indole carboxamide. Plus particulièrement, l'invention concerne des composés de formule (I) dans laquelle R1, R2, R3, U et V sont définis ci-après et leurs sels pharmaceutiquement acceptables. Les composés de l'invention sont des inhibiteurs d'IKK2 et peuvent être utiles dans le traitement de troubles associés à une activité IKK2 appropriée (également connue comme IKK$g(b)), telle que la polyarthrite rhumatoïde, l'asthme et la MPOC (maladie pulmonaire obstructive chronique). En conséquence, l'invention concerne également des compositions pharmaceutiques renfermant un composant de l'invention. L'invention concerne également des méthodes d'inhibition de l'activité IKK2 et de traitement de troubles associés utilisant un composé de l'invention ou une composition pharmaceutique renfermant un composé de l'invention.